Cargando…
Traceless Targeting and Isolation of Gene-Edited Immortalized Keratinocytes from Epidermolysis Bullosa Simplex Patients
Epidermolysis bullosa simplex (EBS) is a blistering skin disease caused by dominant-negative mutations in either KRT5 or KRT14, resulting in impairment of keratin filament structure and epidermal fragility. Currently, nearly 200 mutations distributed across the entire length of these genes are known...
Autores principales: | Aushev, Magomet, Koller, Ulrich, Mussolino, Claudio, Cathomen, Toni, Reichelt, Julia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527154/ https://www.ncbi.nlm.nih.gov/pubmed/28765827 http://dx.doi.org/10.1016/j.omtm.2017.06.008 |
Ejemplares similares
-
The Use of Cultured Allogenic Keratinocyte Grafting in a Patient with Epidermolysis Bullosa Simplex
por: Shin, Kee Cheol, et al.
Publicado: (2011) -
Dystonin modifiers of junctional epidermolysis bullosa and models of epidermolysis bullosa simplex without dystonia musculorum
por: Sproule, Thomas J., et al.
Publicado: (2023) -
A Drosophila model of Epidermolysis Bullosa Simplex
por: Bohnekamp, Jens, et al.
Publicado: (2015) -
Laryngeal stenosis associated with epidermolysis bullosa simplex
por: Devergne, Cécile, et al.
Publicado: (2020) -
An RNA-targeted therapy for dystrophic epidermolysis bullosa
por: Peking, Patricia, et al.
Publicado: (2017)